The NURO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NURO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The NURO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View NURO Detailed Price Forecast - CNN Money | View NURO Detailed Summary - Google Finance | ||
View NURO Detailed Summary - Yahoo! Finance | View NURO Stock Research & Analysis - Zacks.com |
View NURO Trends & Analysis - Trade-Ideas | View NURO Major Holders - Barrons | ||
View NURO Call Transcripts - NASDAQ | View NURO Breaking News & Analysis - Seeking Alpha | ||
View NURO Annual Report - CompanySpotlight.com | View NURO OTC Short Report - OTCShortReport.com | ||
View NURO Fundamentals - TradeKing | View NURO SEC Filings - Bar Chart | ||
View Historical Prices for NURO - The WSJ | View Performance/Total Return for NURO - Morningstar | ||
View the Analyst Estimates for NURO - MarketWatch | View the Earnings History for NURO - CNBC | ||
View the NURO Earnings - StockMarketWatch | View NURO Buy or Sell Recommendations - MacroAxis | ||
View the NURO Bullish Patterns - American Bulls | View NURO Short Pain Metrics - ShortPainBot.com |
View NURO Stock Mentions - StockTwits | View NURO Stock Mentions - PennyStockTweets | ||
View NURO Stock Mentions - Twitter | View NURO Investment Forum News - Investor Hub | ||
View NURO Stock Mentions - Yahoo! Message Board | View NURO Stock Mentions - Seeking Alpha |
View Insider Transactions for NURO - SECform4.com | View Insider Transactions for NURO - Insider Cow | ||
View NURO Major Holdings Summary - CNBC | View Insider Disclosure for NURO - OTC Markets | ||
View Insider Transactions for NURO - Yahoo! Finance | View Institutional Holdings for NURO - NASDAQ |
View NURO Stock Insight & Charts - FinViz.com | View NURO Investment Charts - StockCharts.com | ||
View NURO Stock Overview & Charts - BarChart | View NURO User Generated Charts - Trading View |
NeuroMetrix, Inc.'s (NASDAQ:NURO) CEO Might Not Expect Shareholders To Be So Generous This Year
Posted on Wednesday April 24, 2024
Key Insights NeuroMetrix to hold its Annual General Meeting on 30th of April CEO Shai Gozani's total compensation...
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
Posted on Friday April 19, 2024
Joshua S. Horowitz joins Board of DirectorsAt-the-market equity facility terminated WOBURN, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced two steps to enhance shareholder value following feedback and recommendations from one of its largest shareholders, Ephraim Fields of Echo Lake Capital. The Board has approved the appointment of Joshua S. Horowitz as a new independent director with a 1-year term. Mr. Horowitz is a professional investor with over 22
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
Posted on Thursday March 14, 2024
WOBURN, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of a large study demonstrating that DPNCheck® combined with standard EKG or DPNCheck alone accurately detects diabetic peripheral neuropathy (DPN). Hayashi and colleagues evaluated 167 patients with Type 1 or Type 2 diabetes. The reference standard for DPN was a gold standard nerve conduction study. The authors developed a predictive formula based on DPNCheck measurements, patient age
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
Posted on Wednesday March 13, 2024
WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in December 2022. “We have been pleased by the positive response to Quell Fibromyalgia from providers taking care of patients with fibromyalgia during our strategic launch phase,” said Shai N. Gozani, M.D., Ph.D., Chief Executive Officer of NeuroMetrix. “This early adoption affirms the